Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at treatment for children and young adults with an ependymoma (SIOP Ependymoma Program II) Pathway 3

Overview

Cancer types:

Brain (and spinal cord) tumours, Children's cancers

Status:

Open

Phase:

Phase 2

Details

This trial is looking at adding valproic acid to chemotherapy after surgery to treat ependymoma. It is open to children younger than 1 year old and those with an ependymoma who can’t have radiotherapy after surgery to remove their tumour. Cancer Research UK supports this trial.

There are 2 parts to this trial. In the 1st part the trial committee looks at the results of your tests and scans. The 2nd part is looking at treatment pathways.

There are 3 treatment pathways in this trial. This information is about pathway 3. We have information on pathway 1 and pathway 2.

Recruitment start: 12 February 2016

Recruitment end: 12 February 2026

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor R Grundy

Supported by

Cancer Research UK

Centre Léon Bérard

University of Birmingham

Other information

This is Cancer Research UK trial number CRUK/12/036.

Last reviewed: 07 Feb 2025

CRUK internal database number: 14012

Help and support